NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Connecta Therapeutics

Connecta Therapeutics

Private
BarcelonaHealthcare & Life Scienceshttps://connectatherapeutics.com/

Last Round

Grant

Sep 9, 2025

Total Funding Raised

$8.56M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Connecta Therapeutics is a biotechnology company developing new treatments for central nervous system (CNS) disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Government Contracts, Revenue Share

AI Layer

Application

Keywords

Fragile X Syndrome therapyCNS disordersdisease-modifying therapyneuroplasticity modulatorsmall molecule drugneurodevelopmental disordersclinical-stage biotechAI drug discoveryin-silico drug discoveryneurotherapeuticsTrkB modulatorpharma licensingorphan drug designationnetwork pharmacologyRett syndrome

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Connecta Therapeutics Comparables

Compare Connecta Therapeutics with similar companies based on industry and business-model similarity.

Connecta Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Confluence Pharmaceuticals
84%
Nospharma
80%
Spinogenix, Inc.
79%

Connecta Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 9, 2025
GrantFeb 12, 2024
DebtJun 6, 2023
GrantFeb 3, 2022
SeedSep 28, 2020

Key People

Founding team and executive leadership

Josep Prous

Co-Founder And Chief Scientific Officer

Founding Team

Jordi Fabrega

Cofounder And CEO

Founding Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 9, 2025

    Secured $2.73M from the European Innovation Council.

  • Jul 1, 2025

    Monthly visitors grew 236% MoM, reaching 1K.

Connecta Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Connecta Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Connecta Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersBarcelona
Employee Range8
Year Founded2019
Last FundingSep 9, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.